10 patients enrolled with 100% implantation success Adona's adjustable interatrial shunt is designed so it can be modified post-implantation to provide a more adaptive and personalized lifetime ...
MedPage Today on MSN
Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication
Ventura's permanent interatrial shunt was designed to shunt blood from the left to right atrium to improve symptoms in ...
MedPage Today on MSN
FDA panel on interatrial shunt for heart failure: It's a hard no
An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way.
An FDA advisory panel unanimously agreed that Johnson & Johnson MedTech's V-Wave Ventura interatrial shunt's risks outweigh ...
The FDA’s Circulatory System Devices Panel voted not to recommend approving use of an interatrial shunt to improve heart failure symptoms and prognosis.In a 0-15 vote, the committee determined risk ...
For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...
Children born with defects that impair the heart's lower chambers undergo a series of invasive surgeries early in life. The first surgery includes implantation of a plastic tube called a shunt to ...
SCOTTSDALE, Ariz., May 23, 2023 /PRNewswire/ -- Anuncia Medical Inc. ("Anuncia" or the "Company"), a company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback